These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29455596)

  • 1. 2007 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary.
    J Oncol Pract; 2007 May; 3(3):175-177. PubMed ID: 29455596
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update: ASCO Guideline Q and A.
    Virgo KS; Rumble RB; Talcott JA
    JCO Oncol Pract; 2023 Oct; 19(10):843-846. PubMed ID: 37463395
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
    Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI;
    J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
    Loblaw DA; Mendelson DS; Talcott JA; Virgo KS; Somerfield MR; Ben-Josef E; Middleton R; Porterfield H; Sharp SA; Smith TJ; Taplin ME; Vogelzang NJ; Wade JL; Bennett CL; Scher HI;
    J Clin Oncol; 2004 Jul; 22(14):2927-41. PubMed ID: 15184404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
    Virgo KS; Rumble RB; Talcott J
    J Clin Oncol; 2023 Jul; 41(20):3652-3656. PubMed ID: 37011338
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies surrounding androgen deprivation for prostate cancer.
    Patterson SG; Balducci L; Pow-Sang JM
    Cancer Control; 2002; 9(4):315-25. PubMed ID: 12228757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castration-resistant prostate cancer: AUA Guideline.
    Cookson MS; Roth BJ; Dahm P; Engstrom C; Freedland SJ; Hussain M; Lin DW; Lowrance WT; Murad MH; Oh WK; Penson DF; Kibel AS
    J Urol; 2013 Aug; 190(2):429-38. PubMed ID: 23665272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
    Walsh PC
    J Urol; 2005 Jun; 173(6):1966. PubMed ID: 15879792
    [No Abstract]   [Full Text] [Related]  

  • 9. 2005 Update of ASCO Practice Guideline Recommendations for Colorectal Cancer Surveillance: Guideline Summary.
    J Oncol Pract; 2005 Nov; 1(4):137-139. PubMed ID: 29442584
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of hormone-sensitive metastatic prostate cancer.
    Agarwal N; Hussain M
    Hematol Oncol Clin North Am; 2013 Dec; 27(6):1221-41, viii. PubMed ID: 24188260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
    Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL
    Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCO 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma: Guideline Summary.
    J Oncol Pract; 2007 Jul; 3(4):236. PubMed ID: 29452503
    [No Abstract]   [Full Text] [Related]  

  • 13. [What's new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings].
    Salomon L; Peyromaure M; Mongiat-Artus P; Roset F; Gachignard N; Bastide C; Richaud P; Beuzeboc P; Cornud F; Molinié V; Soulié M; Benchikh El Fegoun A;
    Prog Urol; 2010 Mar; 20 Suppl 1():S61-7. PubMed ID: 20493449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
    J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2006 Update of ASCO Practice Guideline Recommendations for the Use of White Blood Cell Growth Factors: Guideline Summary.
    J Oncol Pract; 2006 Jul; 2(4):196-201. PubMed ID: 29452013
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.
    Van Poznak C; Somerfield MR; Barlow WE; Biermann JS; Bosserman LD; Clemons MJ; Dhesy-Thind SK; Dillmon MS; Eisen A; Frank ES; Jagsi R; Jimenez R; Theriault RL; Vandenberg TA; Yee GC; Moy B
    J Clin Oncol; 2017 Dec; 35(35):3978-3986. PubMed ID: 29035643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Qualitative and quantitative hormonal regulation in castration-resistant prostate cancer].
    Murez T; Basset V; Audenet F; Lebret T; Branchereau J
    Prog Urol; 2013 Oct; 23 Suppl 1():S1-8. PubMed ID: 24314734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.
    Resnick MJ; Lacchetti C; Bergman J; Hauke RJ; Hoffman KE; Kungel TM; Morgans AK; Penson DF
    J Clin Oncol; 2015 Mar; 33(9):1078-85. PubMed ID: 25667275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.
    Taplitz RA; Kennedy EB; Flowers CR
    J Oncol Pract; 2018 Nov; 14(11):692-695. PubMed ID: 30179525
    [No Abstract]   [Full Text] [Related]  

  • 20. [First line therapy in the treatment of metastatic prostate cancer].
    Sakai H; Kanetake H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.